Bloomberg Businessweek
Bloomberg Businessweek (Photo credit: SimonQ????)

China Cord Blood closes $65M financing deal – BusinessWeek.

China Cord Blood Corp. said Friday that it closed a $65 million convertible debt financing deal with an investment fund managed by Kohlberg Kravis Roberts & Co. KKR partner Julian Wolhardt, who has focused on private equity deals in China, was named to the China Cord board. China Cord collects, tests, processes and stores umbilical cord blood that contains stem cells, which can be used to treat certain diseases. Read More

Enhanced by Zemanta